Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer

Clinical trial NCT07323641 · RECRUITING

Trial details

NCT number: NCT07323641
Sponsor: Jonsson Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Non-Small Cell Carcinoma

Start date: 2026-02-19
Primary completion: 2027-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.